<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00919659</url>
  </required_header>
  <id_info>
    <org_study_id>C25.0</org_study_id>
    <nct_id>NCT00919659</nct_id>
  </id_info>
  <brief_title>Parenteral Nutrition Support for Patients With Pancreatic Cancer</brief_title>
  <official_title>Parenteral Nutrition Support for Patients With Pancreatic Cancer. A Phase II Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CONKO-Studiengruppe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fresenius AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>CONKO-Studiengruppe</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the additional nutrition support is
      improving the nutritional status of patients suffering cancer caxechia or not.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32
      pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance
      analysis (BIA) as a proven tool for nutritional investigation in patients with chronic
      disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in
      several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive
      pulmonary disease lung cancer and pancreatic cancer.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2002</start_date>
  <completion_date type="Actual">May 2004</completion_date>
  <primary_completion_date type="Actual">January 2004</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>nutritional status presented by phase angle</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>quantity of port infections, quantity of oedema, quantity of diarrhea</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Cancer Cachexia</condition>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>parenteral nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>25kcal/kg/bw /day via parenteral support</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>parenteral nutrition</intervention_name>
    <description>25kcal/kg bw with parenteral nutrition</description>
    <arm_group_label>parenteral nutrition</arm_group_label>
    <other_name>no specific brand name</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histological proved pancreatic cancer

          -  progressive cancer cachexia

          -  refractive to enteral supplementation

          -  informed consent

        Exclusion Criteria:

          -  prefinal status

          -  septic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>helmut oettle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CONKO-Studiengruppe</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsmedizin Berlin - Charité</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.conko-studien.de</url>
    <description>study group homepage</description>
  </link>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2009</study_first_submitted>
  <study_first_submitted_qc>June 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2009</study_first_posted>
  <last_update_submitted>June 11, 2009</last_update_submitted>
  <last_update_submitted_qc>June 11, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 12, 2009</last_update_posted>
  <responsible_party>
    <name_title>Helmut Oettle MD</name_title>
    <organization>Universitätsmedizin Berlin - Charité</organization>
  </responsible_party>
  <keyword>parenteral nutrition</keyword>
  <keyword>cancer cachexia</keyword>
  <keyword>pancreatic cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Cachexia</mesh_term>
    <mesh_term>Wasting Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

